609.15
6.20%
Accumulate: Emami Ltd.
Dolat Capital
Emami's Q2FY21 results came ahead of our estimates. Domestic business jumped 13%, while IB posted 11% revenue growth in Q2. Ex-winter products (88% contri) reported 28% growth was encouraging performance. Kesh King and Pain management range recorded highest ever quarterly sales during the quarter....
Emami Ltd. is trading above its 150 day SMA of 584.6
More from Emami Ltd.
Recommended